Tagged as: Goodwin

Goodwin Presents on Practical Considerations for Foreign Developers Launching a Biosimilar in the US at JP Morgan Healthcare Conference

Goodwin and the Big Molecule Watch team are looking forward to participating in the 37th Annual JP Morgan Healthcare Conference, bringing together industry leaders from across the country. If you are at the conference in San Francisco, we hope you will join the team today, January 9, 2019 for our…

Read More

Big Molecule Watch Editor Nick Mitrokostas to Speak at ACI Annual Biosimilars Summit

On June 25-June 27th, at the Intercontinental New York Times Square, industry leaders from both innovator and biosimilar companies will convene at ACI’s 9th Annual Summit on Biosimilars to discuss the future of biosimilars and formulate solutions to the complex regulatory and patent challenges ahead. Goodwin is a proud sponsor…

Read More